{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-007222","form_type":"8-K","ticker":"HEPA","cik":"0001583771","company_name":"Hepion Pharmaceuticals, Inc.","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.703429+00:00","generated_at":"2026-06-05T23:05:14.470273+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Chairman Gary Jacob resigns from Hepion board; John Brancaccio appointed Chairman","bullets":["Dr. Gary Jacob resigned as Chairman and from the Board on February 20, 2024, for personal reasons.","Board appointed John Brancaccio as new Chairman effective immediately.","John Cavan continues as Interim CEO and CFO."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-007222","json":"https://secwatch.observer/filing/0001493152-24-007222.json","markdown":"https://secwatch.observer/filing/0001493152-24-007222.md","text":"https://secwatch.observer/filing/0001493152-24-007222.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/0001493152-24-007222-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T23:05:14.470273+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c52bc847dc","claim":"John Brancaccio was appointed as Chairman at Hepion Pharmaceuticals, Inc..","evidence_excerpt":"Dr. Jacob was Chairman of the Company and the Board of Directors appointed John Brancaccio as Chairman.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/0001493152-24-007222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chairman"}],"fact_type":"executive_change"},{"claim_id":"fb179dc8b0","claim":"Gary Jacob resigned as Chairman of the Board at Hepion Pharmaceuticals, Inc..","evidence_excerpt":"On February 20, 2024, Dr. Gary Jacob resigned from the Board of Directors of Hepion Pharmaceuticals, Inc. (the “Company”) for personal reasons.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1583771/000149315224007222/0001493152-24-007222-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chairman of the Board"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}